Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lampalizumab Extension Study in Geographic Atrophy
NCT01602120Phase 2Terminated
- Sponsor
- Genentech
- Start
- May 2012
- Primary completion
- Nov 2017
- Modality
- Antibody Fragments
- Countries
- 2
01
Overview
A Phase 2 trial of lampalizumab in geographic atrophy (GA), sponsored by Genentech. Started May 2012; status: terminated.
02
Drugs
lampalizumab
03
Conditions
geographic atrophy (GA)
Beyond the preview
Go deeper on NCT01602120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01602120.